Education and Prevention
Promotion of health and prevention in priority chronic diseases
The Health Innovation Hub has launched a project focused on prevention and education in non-communicable chronic diseases. Its goal is to develop an innovative and effective framework for impactful campaigns that can be scaled nationally and strengthen prevention efforts.
Strategic Directions of the Project
Collaboration among universities, industry, and patients in creating campaigns
Establishing partnerships between academic institutions and sponsors to run campaigns tailored to each type of priority chronic disease
Aligning this initiative with other upcoming prevention projects scheduled for launch in 2024
Chronic Diseases
Non-communicable chronic diseases present a major challenge to the healthcare system, with a significant societal impact: over 90% of deaths across Europe are caused by these conditions. In Romania, the mortality rate from treatable causes stands at 235 per 100,000 inhabitants—2.5 times the EU average.
Many of these illnesses are preventable. The National Health Strategy outlines directions to address them, aiming to improve quality of life and life expectancy in Romania, which currently lags the EU average by 5.4 years.
The priority non-communicable chronic diseases included in the National Health Strategy 2023–2030 are: cardiovascular diseases (hypertension, acute myocardial infarction, heart failure); liver diseases (non-alcoholic steatohepatitis, liver cirrhosis); metabolic conditions (diabetes mellitus, obesity, osteoporosis); neurological disorders (stroke); oncological and onco-hematological diseases; mental health conditions (depression, dementia); renal diseases (chronic kidney disease); respiratory diseases (COPD, bronchial asthma, chronic respiratory failure).
The project began with a hands-on workshop—a concrete first step—to identify the main challenges in prevention and education for Romania’s priority chronic diseases, and to establish a framework for developing disease-specific campaigns alongside key health stakeholders including authorities, academia, the medical community, patient associations, industry, and other interested entities.